Delisting Determination, The Nasdaq Stock Market, LLC, December 27, 2023,
Evelo Biosciences, Inc.
The Nasdaq Stock Market LLC (the Exchange) has determined to remove
from listing the securities of Evelo Biosciences, Inc., effective
at the opening of the trading session on January 8, 2024.
Based on review of information provided by the Company, Nasdaq
Staff determined that the Company no longer qualified for listing
on the Exchange pursuant to Listing Rules 5101.
The Company was notified of the Staff determination on December 1, 2023.
The Company did not appeal the Staff determination to the Hearings Panel.
The Company securities were suspended on December 12, 2023. The Staff
determination to delist the Company securities became final on
December 12, 2023.